Skip to main content

Table 2 Results of inflammatory markers according to insulin resistance status

From: Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

  All patients (N = 55) Insulin resistance
Yes (n = 30) No (n = 25) p
White blood cell (ц/L) (min-max) 6700 (3100–11100) 7550 (4100–11100) 6100 (3100–8900) 0.004
Neutrophile (ц/L) (min-max) 4330 (1581–8991) 4805 (1827–8991) 3538 (1581–6597) 0.005
Lymphoctye (ц/L) (min-max) 1155 (585–2115) 1188 (640–1905) 1103 (585–2115) 0.4
Platelet (ц/L) (min-max) 282000 (172000–418000) 28200 (172000–41800) 262000 (174000–361000) 0.1
Neutrophil-lymphoctye ratio (NLR) (median) (min-max) 3.3 (min 1.9–max 7.6) 3.6 (min 2.2–7.6) 3.03 (min 1.9–max 5.2) 0.02
Platelet-lymphoctye ratio (PLR) (median) (min-max) 225.3 (min 101.6–max 418.8) 230.8 (min 126.8–max 390.2) 223.1 (min101.6–max 418.8) 0.8
Systemic inflammation index (SII) (median) (min-max) 963 (min 440–max 2458) 999 (min 511–max 2458) 884 (min 440–max 1438) 0.01
CRP (mg/L) (median) (min-max) 3.4 (1.59–43) 4.3 (2–43) 3.3 (1.5–12.5) 0.01